Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder
[Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is...
Saved in:
Published in: | International journal of pharmaceutics Vol. 555; pp. 198 - 206 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
30-01-2019
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | [Display omitted]
3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms. |
---|---|
AbstractList | 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms. [Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms. |
Author | Baier, Andrea Infanger, Sophia Haemmerli, Alexander Iliev, Simona Stoyanov, Edmont Quodbach, Julian |
Author_xml | – sequence: 1 givenname: Sophia surname: Infanger fullname: Infanger, Sophia organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland – sequence: 2 givenname: Alexander surname: Haemmerli fullname: Haemmerli, Alexander organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland – sequence: 3 givenname: Simona surname: Iliev fullname: Iliev, Simona organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland – sequence: 4 givenname: Andrea surname: Baier fullname: Baier, Andrea organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland – sequence: 5 givenname: Edmont surname: Stoyanov fullname: Stoyanov, Edmont organization: Nisso Chemical Europe GmbH, Berliner Allee 42, 40212 Duesseldorf, Germany – sequence: 6 givenname: Julian orcidid: 0000-0003-2471-4502 surname: Quodbach fullname: Quodbach, Julian email: julian.quodbach@hhu.de organization: Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstrasse 1, 40225 Duesseldorf, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30458260$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkM1u1DAUhS1URKeFRwB5ySbBjuOfWSHUAkWqBIvuLce-mTjyxIOdTJu3x6MZ2LLylXzuPed8N-hqihMg9J6SmhIqPo21Hw-DSfu6IVTVlNakVa_QhirJKtZKcYU2hElVcSrZNbrJeSSEiIayN-iakZarRpANGn_FZwcJd-Awu68OyU-zn3Y49njwuyGsOETjyqdLyw47CP4IaS3D0VvI-NnPAx5Wl-LLekjxsAZsIYQlxAzYZJxj8A53fioeb9Hr3oQM7y7vLXr69vXp7qF6_Pn9x92Xx8qyLZ0rSlu1NVy0XWdMxxV3JfXWKG4sVaUCsZQ1ojOiN1vSSymIU0aVYkZKU-rdoo_nsyXP7wXyrPc-n0KZCeKSdZEIzpuWySLlZ6lNMecEvS799yatmhJ9oqxHfaGsT5Q1pbpQLnsfLhZLtwf3b-sv1iL4fBZA6Xn0kHS2HiYLziews3bR_8fiDwVtkxU |
CitedBy_id | crossref_primary_10_3390_pharmaceutics13081212 crossref_primary_10_2174_1567201821666230915150544 crossref_primary_10_1016_j_pmatsci_2020_100684 crossref_primary_10_1016_j_ijpharm_2022_121555 crossref_primary_10_3390_pharmaceutics12020124 crossref_primary_10_1016_j_ajps_2021_02_003 crossref_primary_10_1208_s12249_020_01905_8 crossref_primary_10_3390_pharmaceutics14102179 crossref_primary_10_1016_j_addma_2019_101025 crossref_primary_10_55971_EJLS_1181158 crossref_primary_10_1016_j_ejps_2022_106280 crossref_primary_10_1016_j_ijpx_2022_100151 crossref_primary_10_1016_j_addr_2021_05_003 crossref_primary_10_1016_j_foodchem_2024_140348 crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023046832 crossref_primary_10_1088_1748_605X_ad2a3a crossref_primary_10_1016_j_xphs_2020_06_027 crossref_primary_10_3390_pharmaceutics15020395 crossref_primary_10_3390_pharmaceutics15041152 crossref_primary_10_1016_j_ajps_2020_06_003 crossref_primary_10_22159_ajpcr_2022_v15i8_45136 crossref_primary_10_1016_j_addr_2021_113943 crossref_primary_10_1016_j_xphs_2021_08_030 crossref_primary_10_1208_s12249_022_02321_w crossref_primary_10_1016_j_ejpb_2023_11_023 crossref_primary_10_1002_VIW_20200126 crossref_primary_10_1039_D0RA03620J crossref_primary_10_1016_j_jphotobiol_2021_112201 crossref_primary_10_3390_ma13214961 crossref_primary_10_1016_j_ijpharm_2021_120330 crossref_primary_10_1016_j_jconrel_2021_02_027 crossref_primary_10_1080_17425247_2021_2011856 crossref_primary_10_3390_pharmaceutics11040150 crossref_primary_10_2174_1381612825666190507115504 crossref_primary_10_3390_pharmaceutics14112320 crossref_primary_10_1007_s40964_020_00127_5 crossref_primary_10_1016_j_apsb_2021_03_015 crossref_primary_10_3390_pharmaceutics15092193 crossref_primary_10_1111_bcpt_13974 crossref_primary_10_3390_pharmaceutics14081568 crossref_primary_10_1016_j_ijpharm_2020_119653 crossref_primary_10_1039_D1QM00390A crossref_primary_10_1021_acsnano_3c11432 crossref_primary_10_1016_j_ijpharm_2022_122066 crossref_primary_10_1016_j_ijpx_2023_100179 crossref_primary_10_1016_j_jconrel_2022_09_023 crossref_primary_10_1016_j_ijpharm_2022_122540 crossref_primary_10_1007_s11095_021_03041_9 crossref_primary_10_1016_j_apsb_2021_05_014 crossref_primary_10_1016_j_ijpx_2024_100256 crossref_primary_10_3390_molecules27092784 crossref_primary_10_1016_j_powtec_2021_05_050 crossref_primary_10_1080_01932691_2023_2289623 crossref_primary_10_1007_s40005_020_00498_5 crossref_primary_10_1016_j_scienta_2023_111884 crossref_primary_10_1016_j_ijpharm_2020_119820 crossref_primary_10_3390_pharmaceutics13030358 crossref_primary_10_3390_compounds4010004 crossref_primary_10_1016_j_addma_2020_101209 crossref_primary_10_1016_j_ijpharm_2023_123506 crossref_primary_10_3390_pharmaceutics14122589 crossref_primary_10_1016_j_xphs_2022_08_030 crossref_primary_10_1016_j_addr_2023_114859 crossref_primary_10_1093_jpp_rgab146 crossref_primary_10_1016_j_ijpharm_2021_120791 crossref_primary_10_3390_pharmaceutics12070620 crossref_primary_10_1016_j_ijpharm_2023_123101 crossref_primary_10_3390_pharmaceutics16030317 crossref_primary_10_1186_s43088_020_00040_4 crossref_primary_10_1016_j_pmatsci_2020_100707 |
Cites_doi | 10.1002/jps.2600501018 10.1056/NEJMp1006304 10.1016/S0168-3659(99)00225-4 10.1002/jps.2600521210 10.1208/s12249-018-1012-5 10.1016/j.ijpharm.2015.12.071 10.1016/j.addr.2018.05.006 10.1016/S0168-3659(99)00224-2 10.1016/j.addr.2016.01.003 10.1016/j.ijpharm.2008.12.008 10.1080/03639040500519300 10.1016/0168-3659(95)00173-5 10.1016/S0928-0987(01)00095-1 10.1248/cpb.22.2346 10.1002/adhm.201800417 10.1007/s11095-011-0450-5 10.1517/17425247.2013.859134 10.1056/NEJMp1500523 |
ContentType | Journal Article |
Copyright | 2018 Elsevier B.V. Copyright © 2018 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2018 Elsevier B.V. – notice: Copyright © 2018 Elsevier B.V. All rights reserved. |
DBID | NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.ijpharm.2018.11.048 |
DatabaseName | PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-3476 |
EndPage | 206 |
ExternalDocumentID | 10_1016_j_ijpharm_2018_11_048 30458260 S037851731830872X |
Genre | Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXUO ABFNM ABFRF ABJNI ABMAC ABOCM ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSP SSZ T5K TEORI ~02 ~G- AAQFI AAXKI AKRWK NPM .GJ 29J 3O- 53G 5VS AAQXK AAYXX ABXDB ADMUD AFJKZ ASPBG AVWKF AZFZN CITATION FEDTE FGOYB G-2 HMT HVGLF HZ~ R2- SEW SPT WUQ ZXP 7X8 |
ID | FETCH-LOGICAL-c391t-11489a564bbaab585d0629a85ac180000c1326ba6fa90f7760d8a8621a77a213 |
ISSN | 0378-5173 |
IngestDate | Fri Oct 25 21:51:12 EDT 2024 Thu Sep 26 16:34:43 EDT 2024 Wed Oct 16 00:51:37 EDT 2024 Fri Feb 23 02:29:54 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Drop-on-powder Inkjet Binder free Individualized medicine 3D-printing Drop-on-solid |
Language | English |
License | Copyright © 2018 Elsevier B.V. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c391t-11489a564bbaab585d0629a85ac180000c1326ba6fa90f7760d8a8621a77a213 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-2471-4502 |
PMID | 30458260 |
PQID | 2136552437 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2136552437 crossref_primary_10_1016_j_ijpharm_2018_11_048 pubmed_primary_30458260 elsevier_sciencedirect_doi_10_1016_j_ijpharm_2018_11_048 |
PublicationCentury | 2000 |
PublicationDate | 2019-01-30 |
PublicationDateYYYYMMDD | 2019-01-30 |
PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-30 day: 30 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International journal of pharmaceutics |
PublicationTitleAlternate | Int J Pharm |
PublicationYear | 2019 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Arndt, Kleinebudde (b0005) 2017 Machida, Nagai (b0070) 1974; 22 Wu, Borland, Giordano, Cima, Sachs, Cima (b0095) 1996; 40 Costa, Sousa Lobo (b0025) 2001; 13 Hamburg, Collins (b0040) 2010; 363 Katstra, Palazzolo, Rowe, Giritlioglu, Teung, Cima (b0055) 2000; 66 Arndt, Kleinebudde (b0010) 2018 Yu, Yu, Branford-White, Ma, Zhu, Li, Yang (b0100) 2009; 370 Lim, Kathuria, Tan, Kang (b0065) 2018 Higuchi (b0050) 1963; 52 Kolakovic, Viitala, Ihalainen, Genina, Peltonen, Sandler (b0060) 2013; 10 Qi, Craig (b0075) 2016 Wang, Tejwani, Roach, Kay, Yoo, Surprenant, Monkhouse, Pryor (b0090) 2006; 32 Rowe, Katstra, Palazzolo, Giritlioglu, Teung, Cima (b0080) 2000; 66 Buanz, Saunders, Basit, Gaisford (b0015) 2011; 28 Collins, Varmus (b0020) 2015; 372 Goole, Amighi (b0035) 2016; 499 Ghosh, Ning, Wang, Kong (b0030) 2018; 7 Schulze (b0085) 2008 Higuchi (b0045) 1961; 50 Qi (10.1016/j.ijpharm.2018.11.048_b0075) 2016 Buanz (10.1016/j.ijpharm.2018.11.048_b0015) 2011; 28 Schulze (10.1016/j.ijpharm.2018.11.048_b0085) 2008 Hamburg (10.1016/j.ijpharm.2018.11.048_b0040) 2010; 363 Higuchi (10.1016/j.ijpharm.2018.11.048_b0045) 1961; 50 Rowe (10.1016/j.ijpharm.2018.11.048_b0080) 2000; 66 Arndt (10.1016/j.ijpharm.2018.11.048_b0010) 2018 Collins (10.1016/j.ijpharm.2018.11.048_b0020) 2015; 372 Katstra (10.1016/j.ijpharm.2018.11.048_b0055) 2000; 66 Wu (10.1016/j.ijpharm.2018.11.048_b0095) 1996; 40 Kolakovic (10.1016/j.ijpharm.2018.11.048_b0060) 2013; 10 Machida (10.1016/j.ijpharm.2018.11.048_b0070) 1974; 22 Goole (10.1016/j.ijpharm.2018.11.048_b0035) 2016; 499 Lim (10.1016/j.ijpharm.2018.11.048_b0065) 2018 Arndt (10.1016/j.ijpharm.2018.11.048_b0005) 2017 Wang (10.1016/j.ijpharm.2018.11.048_b0090) 2006; 32 Costa (10.1016/j.ijpharm.2018.11.048_b0025) 2001; 13 Higuchi (10.1016/j.ijpharm.2018.11.048_b0050) 1963; 52 Ghosh (10.1016/j.ijpharm.2018.11.048_b0030) 2018; 7 Yu (10.1016/j.ijpharm.2018.11.048_b0100) 2009; 370 |
References_xml | – volume: 13 start-page: 123 year: 2001 end-page: 133 ident: b0025 article-title: Modeling and comparison of dissolution profiles publication-title: Eur. J. Pharm. Sci. contributor: fullname: Sousa Lobo – volume: 499 start-page: 376 year: 2016 end-page: 394 ident: b0035 article-title: 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems publication-title: Int. J. Pharm. contributor: fullname: Amighi – volume: 40 start-page: 77 year: 1996 end-page: 87 ident: b0095 article-title: Solid free-form fabrication of drug delivery devices publication-title: J. Controlled Release contributor: fullname: Cima – volume: 28 start-page: 2386 year: 2011 ident: b0015 article-title: Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing publication-title: Pharm. Res. contributor: fullname: Gaisford – volume: 7 start-page: 1800417 year: 2018 ident: b0030 article-title: Addressing unmet clinical needs with 3D printing technologies publication-title: Adv. Healthc. Mater. contributor: fullname: Kong – year: 2017 ident: b0005 article-title: Influence of binder properties on dry granules and tablets publication-title: Powder Technol. contributor: fullname: Kleinebudde – volume: 370 start-page: 160 year: 2009 end-page: 166 ident: b0100 article-title: Novel drug delivery devices for providing linear release profiles fabricated by 3DP publication-title: Int. J. Pharm. contributor: fullname: Yang – volume: 363 start-page: 301 year: 2010 end-page: 304 ident: b0040 article-title: The path to personalized medicine publication-title: N. Engl. J. Med. contributor: fullname: Collins – year: 2008 ident: b0085 article-title: Powder and Bulk Solids: Behavior, Characterization, Storage and Flow contributor: fullname: Schulze – year: 2018 ident: b0010 article-title: Roll Compaction and tableting of high loaded metformin formulations using efficient binders publication-title: AAPS PharmSciTech contributor: fullname: Kleinebudde – volume: 372 start-page: 793 year: 2015 end-page: 795 ident: b0020 article-title: A new initiative on precision medicine publication-title: N. Engl. J. Med. contributor: fullname: Varmus – year: 2018 ident: b0065 article-title: 3D printed drug delivery and testing systems — a passing fad or the future? publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Kang – year: 2016 ident: b0075 article-title: Recent developments in micro- and nanofabrication techniques for the preparation of amorphous pharmaceutical dosage forms publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Craig – volume: 66 start-page: 11 year: 2000 end-page: 17 ident: b0080 article-title: Multimechanism oral dosage forms fabricated by three dimensional printing™ publication-title: J. Controlled Release contributor: fullname: Cima – volume: 22 start-page: 2346 year: 1974 end-page: 2351 ident: b0070 article-title: Directly compressed tablets containing hydroxypropyl cellulose in addition to starch or lactose publication-title: Chem. Pharm. Bull. contributor: fullname: Nagai – volume: 32 start-page: 367 year: 2006 end-page: 376 ident: b0090 article-title: Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology publication-title: Drug Dev. Ind. Pharm. contributor: fullname: Pryor – volume: 52 start-page: 1145 year: 1963 end-page: 1149 ident: b0050 article-title: Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices publication-title: J. Pharm. Sci. contributor: fullname: Higuchi – volume: 50 start-page: 874 year: 1961 end-page: 875 ident: b0045 article-title: Rate of release of medicaments from ointment bases containing drugs in suspension publication-title: J. Pharm. Sci. contributor: fullname: Higuchi – volume: 66 start-page: 1 year: 2000 end-page: 9 ident: b0055 article-title: Oral dosage forms fabricated by Three Dimensional Printing™ publication-title: J. Controlled Release contributor: fullname: Cima – volume: 10 start-page: 1711 year: 2013 end-page: 1723 ident: b0060 article-title: Printing technologies in fabrication of drug delivery systems publication-title: Expert Opin. Drug Deliv. contributor: fullname: Sandler – volume: 50 start-page: 874 year: 1961 ident: 10.1016/j.ijpharm.2018.11.048_b0045 article-title: Rate of release of medicaments from ointment bases containing drugs in suspension publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600501018 contributor: fullname: Higuchi – volume: 363 start-page: 301 year: 2010 ident: 10.1016/j.ijpharm.2018.11.048_b0040 article-title: The path to personalized medicine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1006304 contributor: fullname: Hamburg – volume: 66 start-page: 1 year: 2000 ident: 10.1016/j.ijpharm.2018.11.048_b0055 article-title: Oral dosage forms fabricated by Three Dimensional Printing™ publication-title: J. Controlled Release doi: 10.1016/S0168-3659(99)00225-4 contributor: fullname: Katstra – volume: 52 start-page: 1145 year: 1963 ident: 10.1016/j.ijpharm.2018.11.048_b0050 article-title: Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600521210 contributor: fullname: Higuchi – year: 2008 ident: 10.1016/j.ijpharm.2018.11.048_b0085 contributor: fullname: Schulze – year: 2018 ident: 10.1016/j.ijpharm.2018.11.048_b0010 article-title: Roll Compaction and tableting of high loaded metformin formulations using efficient binders publication-title: AAPS PharmSciTech doi: 10.1208/s12249-018-1012-5 contributor: fullname: Arndt – volume: 499 start-page: 376 year: 2016 ident: 10.1016/j.ijpharm.2018.11.048_b0035 article-title: 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2015.12.071 contributor: fullname: Goole – year: 2018 ident: 10.1016/j.ijpharm.2018.11.048_b0065 article-title: 3D printed drug delivery and testing systems — a passing fad or the future? publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2018.05.006 contributor: fullname: Lim – year: 2017 ident: 10.1016/j.ijpharm.2018.11.048_b0005 article-title: Influence of binder properties on dry granules and tablets publication-title: Powder Technol. contributor: fullname: Arndt – volume: 66 start-page: 11 year: 2000 ident: 10.1016/j.ijpharm.2018.11.048_b0080 article-title: Multimechanism oral dosage forms fabricated by three dimensional printing™ publication-title: J. Controlled Release doi: 10.1016/S0168-3659(99)00224-2 contributor: fullname: Rowe – year: 2016 ident: 10.1016/j.ijpharm.2018.11.048_b0075 article-title: Recent developments in micro- and nanofabrication techniques for the preparation of amorphous pharmaceutical dosage forms publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2016.01.003 contributor: fullname: Qi – volume: 370 start-page: 160 year: 2009 ident: 10.1016/j.ijpharm.2018.11.048_b0100 article-title: Novel drug delivery devices for providing linear release profiles fabricated by 3DP publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2008.12.008 contributor: fullname: Yu – volume: 32 start-page: 367 year: 2006 ident: 10.1016/j.ijpharm.2018.11.048_b0090 article-title: Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology publication-title: Drug Dev. Ind. Pharm. doi: 10.1080/03639040500519300 contributor: fullname: Wang – volume: 40 start-page: 77 year: 1996 ident: 10.1016/j.ijpharm.2018.11.048_b0095 article-title: Solid free-form fabrication of drug delivery devices publication-title: J. Controlled Release doi: 10.1016/0168-3659(95)00173-5 contributor: fullname: Wu – volume: 13 start-page: 123 year: 2001 ident: 10.1016/j.ijpharm.2018.11.048_b0025 article-title: Modeling and comparison of dissolution profiles publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(01)00095-1 contributor: fullname: Costa – volume: 22 start-page: 2346 year: 1974 ident: 10.1016/j.ijpharm.2018.11.048_b0070 article-title: Directly compressed tablets containing hydroxypropyl cellulose in addition to starch or lactose publication-title: Chem. Pharm. Bull. doi: 10.1248/cpb.22.2346 contributor: fullname: Machida – volume: 7 start-page: 1800417 year: 2018 ident: 10.1016/j.ijpharm.2018.11.048_b0030 article-title: Addressing unmet clinical needs with 3D printing technologies publication-title: Adv. Healthc. Mater. doi: 10.1002/adhm.201800417 contributor: fullname: Ghosh – volume: 28 start-page: 2386 year: 2011 ident: 10.1016/j.ijpharm.2018.11.048_b0015 article-title: Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing publication-title: Pharm. Res. doi: 10.1007/s11095-011-0450-5 contributor: fullname: Buanz – volume: 10 start-page: 1711 year: 2013 ident: 10.1016/j.ijpharm.2018.11.048_b0060 article-title: Printing technologies in fabrication of drug delivery systems publication-title: Expert Opin. Drug Deliv. doi: 10.1517/17425247.2013.859134 contributor: fullname: Kolakovic – volume: 372 start-page: 793 year: 2015 ident: 10.1016/j.ijpharm.2018.11.048_b0020 article-title: A new initiative on precision medicine publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1500523 contributor: fullname: Collins |
SSID | ssj0006213 |
Score | 2.5778794 |
Snippet | [Display omitted]
3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been... 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 198 |
SubjectTerms | 3D-printing Binder free Drop-on-powder Drop-on-solid Individualized medicine Inkjet |
Title | Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder |
URI | https://dx.doi.org/10.1016/j.ijpharm.2018.11.048 https://www.ncbi.nlm.nih.gov/pubmed/30458260 https://search.proquest.com/docview/2136552437 |
Volume | 555 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF6c5NJL6bvuiy2UXBy5eq20OobGJemhGOKDb2L0qm2EZKyoRf--M9rVI6ShD-hFmLVXWvb7PDszmgdjH0Akph35wvAygQZKHEsjShPHMOPEl2AGJkSUjXx57X9dy4uFu5hMumY6w9h_RRrHEGvKnP0LtPub4gB-Rszxiqjj9Y9wX5Y_qDwEbsXMuTDIbdcFNlNl4ryZ5SUk-GVyqL_NkjSnuIyGcqdIYii37KZJKLgFZeu-yWfk2q9zCmuHaoZr36LKSjUWD2O99rZjcVSOYr8ZfOa9-n5VZG26cet6LfebLQyCMCVPusrZ7pNv-nmoMH9vJyHDisGVAFvdk5uiM2HsyKDcKat7J9N61-5k2KisLrRyhaXancxTJaSl7xiOq_rGdFJcCDGSw5Zqba2PdLstanD3tFCOi918u2s3gwL95JxqurpyOB77oMVrWgstBaWgKX17fcRObBRvKF1Pzq8W6y-9BuDZui23XvuQOfbxlw-7Tye6z-ZpdZ_VI_ZQGy38XLHtMZukxRN2ulTQNmd8NSTxVWf8lC-HeujNU7ZTlORIST6iJC8zrijJFSU5UZJ3lOSakpwoyW9RkveU5FDxlpJcUfIZW31erD5dGrrFhxE7gXVjkDUegPDcKAKI0HRNcPMCkAJiS5IuFVtoX0TgZRCYme97ZiIBjXALfB9wl5-z46Is0peMe7GIAH-I4iVDpTQDCLxAOD4IyFy8zZTNuz0O96qQS9hFOO5CDUpIoKBRHCIoUyY7JEKtjSotM0T6_G7q-w65EKU1bQoUaVlXoU1RpYKKgE7ZCwVpv5o2ZsH2zFf__uDX7MHwz3rDjm8OdfqWHVVJ_U5z9CcE68iU |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Powder+bed+3D-printing+of+highly+loaded+drug+delivery+devices+with+hydroxypropyl+cellulose+as+solid+binder&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Infanger%2C+Sophia&rft.au=Haemmerli%2C+Alexander&rft.au=Iliev%2C+Simona&rft.au=Baier%2C+Andrea&rft.date=2019-01-30&rft.pub=Elsevier+B.V&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=555&rft.spage=198&rft.epage=206&rft_id=info:doi/10.1016%2Fj.ijpharm.2018.11.048&rft.externalDocID=S037851731830872X |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon |